Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Movantik® (naloxegol) – New warning
August 22, 2016 – The FDA approved a new update to the Warnings and Precautions section of the Movantik (naloxegol) drug label, regarding severe abdominal pain and/or diarrhea.
